Compare BioSyntech Canada vs Mirus Bio
Customers evaluate the quality of BioSyntech Canada's products using the following success metrics.
Overview
BioSyntech Canada is 30 yrs old and is based in Canada.
BioSyntech specializes in the discovery, development and manufacturing of biotherapeutic thermogels for regenerative medicine and therapeutic delivery. Its platform technology is a family of hydrogels that can be injected or applied to specific sites and which offer beneficial properties for the local repair of damaged tissue such as cartilage, bone and chronic wounds.
Mirus Bio is 29 yrs old and is based in United States.
Mirus Bio is a life science company focused on discovering, developing, and commercializing nucleic acid-based technologies and products. Mirus Bio operates in the fields of RNA interference and gene therapy, specializing in nucleic acid chemistry and delivery. On May 18, 2021, Gamma Biosciences acquired a majority stake in Mirus Bio. The terms of the transaction were not disclosed.
Demo Video
Leadership
Jeanne Bertonis (President)
Vladimir Budker (Founder)
Investors
Pappas Ventures, ProQuest Investments
Gamma Biosciences, Paycheck Protection Program
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because BioSyntech Canada has not claimed their profile.
Work for BioSyntech Canada? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for BioSyntech Canada?
Claim your profile now.
Information not available because Mirus Bio has not claimed their profile.
Work for Mirus Bio? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Mirus Bio?
Claim your profile now.